VAISHALINSEVAISHALI PHARMA LIMITEDMinimalNeutral
Announced Tue, 29 Sept, 2026 · 17:04 IST

Trading window closure for Q2 and half-year results

VAISHALI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.1%Reaction day
₹8.40
prior close
₹8.75
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+0.1% vs market
Pharmaceuticals peers, median of 172sector-0.9%+0.8% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 0.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
-1.7
15m
-4.1
30m
-4.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.1-0.3+0.1-0.9+0.8
Next day
-0.2-1.5+1.3-1.7+1.4
2d
-1.0-1.5+0.6-2.6+1.7
3d
-2.0-0.2-1.8-1.3-0.7
4d
-4.5-0.5-4.0-1.8-2.8
5d
-3.0-3.2+0.3-3.5+0.5
1w
-5.4-2.2-3.2-4.3-1.1
15d
-18.2-9.5-8.7-9.1-9.1
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vaishali Pharma has informed the exchange that its trading window for dealing in company securities will be closed from 1st October 2026. The closure is ahead of the board considering unaudited financial results for the second quarter and half year ending 30th September 2026. The window will reopen 48 hours after the results become publicly available. All officers, designated employees, directors, and auditors have been barred from trading in the company equity shares during this period.

Likely market impact

Routine SEBI compliance filing; signals upcoming Q2 results announcement. No direct stock price impact.